Tracxn’s India Pharma and Healthcare Funding Tracker for May 2025 reveals a major recovery in funding activity. Total funding reached $254.7 million across 10 rounds, representing a 462.36 per cent increase from April 2025 and a 44.20 per cent rise from the same month last year.
Seed-stage funding dominated with 61.9 per cent of total funding. Early-stage funding contributed 18.0 per cent, while late-stage funding comprised 20.1 per cent of the total.
PB Healthcare secured funding of $156 million followed by Vetic ($26.2 million), Pharmazz: ($25.0 million), CureBay ($21.0 million), The Good Bug ($11.9 million), and DentCare ($10.6 million).
In May 2025, several prominent venture capital firms made notable investments in the startup ecosystem. Bessemer Venture Partners participated in a funding round for Vetic, while Bertelsmann India Investments backed CureBay, and SIG Venture Capital invested in The Good Bug. Each of these firms was involved in one funding round, highlighting selective but strategic investment activity during the month.
Key Takeaways:
1. Massive recovery in funding: Funding surged more than 5 times compared to April 2025.
2. Seed-stage rounds lead: Seed investments made up the largest share at over 60 per cent.
3. The top deal alone ($156 million) drove the majority of funding.
This surge suggests renewed investor confidence and growing momentum in India’s pharma and healthcare startup ecosystem.
Source: Express Healthcare
#healthcarestartupfunding #dseidehealthcarenetwork
Seed-stage funding dominated with 61.9 per cent of total funding. Early-stage funding contributed 18.0 per cent, while late-stage funding comprised 20.1 per cent of the total.
PB Healthcare secured funding of $156 million followed by Vetic ($26.2 million), Pharmazz: ($25.0 million), CureBay ($21.0 million), The Good Bug ($11.9 million), and DentCare ($10.6 million).
In May 2025, several prominent venture capital firms made notable investments in the startup ecosystem. Bessemer Venture Partners participated in a funding round for Vetic, while Bertelsmann India Investments backed CureBay, and SIG Venture Capital invested in The Good Bug. Each of these firms was involved in one funding round, highlighting selective but strategic investment activity during the month.
Key Takeaways:
1. Massive recovery in funding: Funding surged more than 5 times compared to April 2025.
2. Seed-stage rounds lead: Seed investments made up the largest share at over 60 per cent.
3. The top deal alone ($156 million) drove the majority of funding.
This surge suggests renewed investor confidence and growing momentum in India’s pharma and healthcare startup ecosystem.
Source: Express Healthcare
#healthcarestartupfunding #dseidehealthcarenetwork
Tracxn’s India Pharma and Healthcare Funding Tracker for May 2025 reveals a major recovery in funding activity. Total funding reached $254.7 million across 10 rounds, representing a 462.36 per cent increase from April 2025 and a 44.20 per cent rise from the same month last year.
Seed-stage funding dominated with 61.9 per cent of total funding. Early-stage funding contributed 18.0 per cent, while late-stage funding comprised 20.1 per cent of the total.
PB Healthcare secured funding of $156 million followed by Vetic ($26.2 million), Pharmazz: ($25.0 million), CureBay ($21.0 million), The Good Bug ($11.9 million), and DentCare ($10.6 million).
In May 2025, several prominent venture capital firms made notable investments in the startup ecosystem. Bessemer Venture Partners participated in a funding round for Vetic, while Bertelsmann India Investments backed CureBay, and SIG Venture Capital invested in The Good Bug. Each of these firms was involved in one funding round, highlighting selective but strategic investment activity during the month.
Key Takeaways:
1. Massive recovery in funding: Funding surged more than 5 times compared to April 2025.
2. Seed-stage rounds lead: Seed investments made up the largest share at over 60 per cent.
3. The top deal alone ($156 million) drove the majority of funding.
This surge suggests renewed investor confidence and growing momentum in India’s pharma and healthcare startup ecosystem.
Source: Express Healthcare
#healthcarestartupfunding #dseidehealthcarenetwork
